Interestingly, the former patient (case 30) developed PBL with t(8;14)(q24.1;q32) and MYC/IGH rearrangement 8 years following therapy for DLBCL (Fig. 1e, f). This evidence concerns the gene MYC and diffuse large B-cell lymphoma.